Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2013 by Hospital Sao Domingos.
Recruitment status was Recruiting
Information provided by (Responsible Party):
José Raimundo Araujo de Azevedo, Hospital Sao Domingos
First received: April 24, 2013
Last updated: April 25, 2013
Last verified: March 2013
The purpose of this study is to compare the tendency of plasma concentration and clearance of procalcitonin in the first 24 and 48 hours of management of patients with severe sepsis and septic shock with another marker of early prognosis represented by 48 hours delta sofa.
||Observational Model: Cohort
Time Perspective: Prospective
||PROGNOSTIC EVALUATION OF SEVERE SEPSIS AND SEPTIC SHOCK. PROCALCITONIN VERSUS DELTA SOFA
Primary Outcome Measures:
- MORTALITY [ Time Frame: 28 DAYS ] [ Designated as safety issue: Yes ]
| Estimated Enrollment:
| Study Start Date:
| Primary Completion Date:
||January 2013 (Final data collection date for primary outcome measure)
This is a cohort prospective observational study that will include adult patients admitted to a multidisciplinary ICU of a tertiary hospital.
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Adult patients with severe sepsis and septic shock admitted to a multidisciplinary ICU
- Adult patients admitted to the ICU
- severe sepsis and septic shock
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01841190
|Hospital Sao Domingos
|Sao Luis, Maranhao, Brazil, 65060-642 |
|Contact: ORLANDO J TORRES, PhD 559832168100 firstname.lastname@example.org |
|Hospital Sao Domingos
|Sao Luis, MA, Brazil, 65060-642 |
|Contact: JOSE R AZEVEDO, MD 55 98 32168110 email@example.com |
|Principal Investigator: JOSE R AZEVEDO, MD |
Hospital Sao Domingos
No publications provided by Hospital Sao Domingos
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
||José Raimundo Araujo de Azevedo, MD. COORDINATOR. ICU., Hospital Sao Domingos
History of Changes
|Other Study ID Numbers:
|Study First Received:
||April 24, 2013
||April 25, 2013
||Brazil: National Committee of Ethics in Research
Keywords provided by Hospital Sao Domingos:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on May 20, 2015
Systemic Inflammatory Response Syndrome